Caribou Biosciences Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Caribou Biosciences is a clinical-stage biotechnology company that develops cell therapies through CRISPR-based genome editing. The firm aims to enable precise genetic modifications and create therapies designed to have enhanced activity against disease. It is pursuing off-the-shelf, allogeneic cell therapies derived from a CAR-T cell platform for the treatment of hematologic malignancies and autoimmune diseases.

Headquartered in Berkeley, California, the company operates within the biotechnology research industry as a mid-sized firm. Its work focuses on delivering readily available cell therapies through allogeneic approaches to address serious diseases with limited treatment options. The emphasis on genome editing and allogeneic cell therapy situates Caribou within the broader field of next-generation cell therapies for oncology and immune-mediated conditions.

Sign up for free to view info

Company overview Employee directory